Garrouste C, Philipponnet C, Kaysi S, Enache I, Tiple A, Heng A E
Department of Nephrology, Dialysis and Renal Transplantation, University Hospital, Clermont-Ferrand, France.
Transplant Proc. 2012 Nov;44(9):2851-2. doi: 10.1016/j.transproceed.2012.09.028.
Using colchicine to treat an acute gout crisis in an organ transplant recipient (TR) on cyclosporine (CsA) may result in life-threatening intoxication. We report the case of a 59-year-old kidney transplant recipient on CsA who was treated with colchicine for acute gout crisis. Seven days later, he developed rhabdomyolysis with progressive quadriparesis, hematologic toxicity and acute renal failure. CsA inhibits P-glycoprotein resulting in decreased hepatic metabolism and renal excretion of colchicine. Colchicine and CsA withdrawal as well as appropriate supportive treatments were effective to manage all of these complications.
在接受环孢素(CsA)治疗的器官移植受者(TR)中,使用秋水仙碱治疗急性痛风发作可能会导致危及生命的中毒。我们报告了一例59岁接受CsA治疗的肾移植受者,其因急性痛风发作接受了秋水仙碱治疗。七天后,他出现横纹肌溶解并伴有进行性四肢瘫痪、血液学毒性和急性肾衰竭。CsA抑制P-糖蛋白,导致秋水仙碱的肝脏代谢和肾脏排泄减少。停用秋水仙碱和CsA以及适当的支持治疗有效地控制了所有这些并发症。